drugset / Trial / NCT02686840

Sublingual Versus Vaginal Misoprostol In Medical Treatment of First Trimestric Missed Miscarriage

NCT02686840 ↗

Phase 3 Completed 200 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this work is to compare the effectiveness of vaginal versus sub-lingual misoprostol for medical treatment of first trimester missed miscarriage.

Timeline

Start
2016-01
Primary completion
2017-01
Completion
2017-03

Outcome

Met primary endpoint

paper By day 7, successful complete abortion was significantly more frequent in the sublingual misoprostol group (71.4%) than in the vaginal misoprostol group (51.5%) (p = .006). PMID 30747547 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 0.8 mg Other